Development and characterization of Luliconazole ethogel for topical use in the treatment of athlete’s foot infection

Authors

  • Dhiraj Kumar Gupta Bhabha Pharmacy Research Institute, Bhabha University, Bhopal-462046, M.P.
  • Om Prakash Agrawal Bhabha Pharmacy Research Institute, Bhabha University, Bhopal-462046, M.P.
  • Sailesh Kumar Ghatuary Bhabha Pharmacy Research Institute, Bhabha University, Bhopal-462046, M.P.

Keywords:

Luliconazole, Etheosome, Ethogel, Method of Preparation

Abstract

Luliconazole is an imidazole antifungal agent with a unique structure, as the imidazole moiety is incorporated into the ketene dithioacetate structure. To develop and optimize the ethosomal formulation of luliconazole for Athlete’s foot infection. Characterization of optimized formulation in vitro. To develop and characterize luliconazole ethosomes loaded topical gel (Ethogel). Anti–fungal study of the optimized ethogel formulation. That ethosomes can become a promising drug carrier in future for not the only topical treatment of local and systemic disorders, but also for the cosmetic and cosmeceutical fields. The present study focused on the development and characterization of LCZ-loaded ethogel and they’re in incorporation in the topical gel to increase the permeation through stratum corneum, imparting controlled release as well as enhancing the hydration of the skin. Therefore, LCZ loaded ethosomes were prepared by Cold method with high-speed homogenization combined with ultra-sonication. The particle size was found to be in the range of 185 to 289 nm and a maximum of 93 % EE and -24.49 mV Zeta potential. ATR and XRD data ruled out any possible incompatibility among the excipient. Release studies confirmed the sustained release nature of ethosomes.

Downloads

Download data is not yet available.

References

Akbarzadeh, “Liposomes: Classification Preparation and Application, "Nanoscale Research letter, 2013; 8: 102.

Akhtar N, Pathak K. Cavamax w7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel. Aaps Pharmscitech, 2012; 13(1): 344-55.

Aute PP, Kamble MS, Chaudhari PD, Bhosale AV. A Comprehensive Review on Ethosomes, 2012.

Baker SJ, Zhang Y-K, Akama T, Lau A, Zhou H, Hernandez V, et al. Discovery of a new boron-containing antifungal agent, 5-fluoro-1, 3-dihydro-1-hydroxy-2, 1- benzoxaborole (AN2690), for the potential treatment of onychomycosis. Journal of medicinal chemistry, 2006; 49(15): 4447-50.

Barupal A, Gupta V, Ramteke S. Preparation and characterization of ethosomes for topical delivery of aceclofenac. Indian journal of pharmaceutical sciences, 2010; 72(5): 582.

Bell‐Syer SE, Khan SM, Torgerson DJ. Oral treatments for fungal infections of the skin of the foot. The Cochrane Library, 2012.

Bhalaria M, Naik S, Misra A. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases, 2009.

Borgers M. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Reviews of infectious diseases, 1980; 2(4): 520-34.

Bushnell LF. Aerosol foam: a practical and effective method of contraception. Pacific medicine and surgery, 1965; 73(6): 353-5.

Dileep P. Vijaya vani CHS, Uma maheshwar Rao V. formulation and evaluation of itraconazole ethosomal gel. International journal of pharmacy Review and research, 2015; 5(2): 85-94.

Paolino D, Celia C, Trapasso E, Cilurzo F, Fresta M. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratosis. European Journal of Pharmaceutics and Bio pharmaceutics, 2012; 81(1): 102-12.

Downloads

Published

2025-10-31

Issue

Section

Research Articles

How to Cite

1.
Development and characterization of Luliconazole ethogel for topical use in the treatment of athlete’s foot infection. Int J Adv Pharm [Internet]. 2025 Oct. 31 [cited 2025 Nov. 10];14(1):e5878. Available from: https://ssjournals.co.in/index.php/ijap/article/view/5878